Apellis PharmaceuticalsListed
apellis.combiotech_life_sciences
Apellis Pharmaceuticals is a biotechnology company focused on developing innovative therapies for patients with serious diseases driven by the complement system. They have pioneer…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Apellis Pharmaceuticals is a biotechnology company focused on developing innovative therapies for patients with serious diseases driven by the complement system. They have pioneer…
Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life with its novel and proprietary ARCUS® genome editing platform, developing in vivo…
RayzeBio is focused on creating precision radiopharmaceutical therapies (RPTs) that transform people’s lives. With an innovation-leading position in actinium-based RPTs and a pipe…
Verona Pharma is developing novel treatments to enhance the lives of those affected by chronic lung conditions.
Harmony Biosciences is focused on developing innovative treatments for rare neurological diseases, particularly in the areas of sleep/wake disorders and rare epilepsy syndromes.
Lyell is a late-stage clinical company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer. Their product candidates are enhanced with novel tech…
Pharvaris is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs and improve standard of care in bradykini…
Alexion Pharmaceuticals is a biotechnology company specializing in rare diseases, a subsidiary of AstraZeneca, focused on developing treatments for conditions like atypical hemoly…
Achieve Life Sciences is a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment for nicotine depende…
Impel Pharmaceuticals is a commercial-stage pharmaceutical company focused on developing first-in-class intranasal drug treatments for disorders with high unmet medical needs, uti…
Ventyx Biosciences develops oral small molecule drugs targeting the NLRP3 inflammasome to treat inflammatory disorders, with applications in cardiometabolic health, neurodegenerat…
Aurinia Pharmaceuticals is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. They introduced LUP…
Akero Therapeutics is focused on developing Efruxifermin (EFX) for the treatment of metabolic diseases, particularly MASH (Metabolic Associated Steatotic Liver Disease).
Vicebio is a biotech company focused on developing vaccines against life-threatening respiratory viral infections using its proprietary Molecular Clamp technology, which stabilize…
Candid Therapeutics is a biotech company focused on developing treatments for fungal infections.
Marea Therapeutics is focused on developing next-generation medicines for cardioendocrine diseases by leveraging large-scale human genetic data and advancements in biology.
35Pharma is dedicated to designing and developing best-in-class ligand traps that target Activin x GDF biology to address diseases with high unmet medical need including pulmonary…
Abdera Therapeutics is a clinical-stage biopharmaceutical company focused on developing precision radiopharmaceuticals for cancer. The company utilizes its proprietary Radio Optim…
Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company focused on the development and commercialization of innovative targeted radiopharmaceutical therapies (TRT) again…
Acelyrin, Inc. is a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology.
Alumis is advancing a late-stage portfolio of next-generation targeted therapies for immune-mediated diseases, designed to optimize impact and transform patient care - helping mil…
Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted and highly selective small molecules to restore cellular metabolic quality control, addre…
Aragon Pharmaceuticals is a small-molecule drug discovery company focused on developing medicines for the treatment of hormonally-driven cancers. The company's lead compound, ARN-…
Arpeggio Bio builds technology to watch and learn how drugs work, leveraging machine learning and biological assays to analyze cellular dynamics and guide therapeutic development.
Arrakis Therapeutics is pioneering a new class of genetic medicines known as RNA-targeted small molecules (rSMs), aiming to unlock new biology for patients by creating oral medici…
Details are not available yet. The company remains listed.
Attovia Therapeutics is a clinical-stage biopharmaceutical company focused on immune-mediated diseases, developing next-generation biologic therapies using its proprietary ATTOBOD…
Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with systemic amyloidosis. Our proprietary pan…
Axent Biosciences is a biotechnology therapeutics company developing next-generation stem cell therapies using engineered biomaterials to address unmet medical needs in human heal…
Caldera Therapeutics is a Boston-based biotechnology company dedicated to developing innovative therapeutic solutions for inflammatory bowel disease and other immunologic conditio…
Checkmate Pharmaceuticals is a clinical stage company pursuing a novel approach to specifically activating the innate and adaptive arms of the immune system to recognize and ultim…
CinCor Pharma is a clinical-stage biopharmaceutical company focused on developing innovative treatments for cardiovascular and renal diseases, particularly through its lead produc…
EndPath Therapeutics is a radiopharmaceutical company focused on developing radioligand therapies for cancer treatment.
Entact Bio is pioneering precision medicines that enhance the function of beneficial proteins, targeting previously undruggable pathways and addressing hard-to-treat genetic disor…
Eyconis is a clinical-stage biotechnology company advancing next-generation, long-acting ophthalmic therapeutics, focusing on improving vision for people with serious eye diseases…
HistoWiz accelerates scientific research and discoveries through the automation of histology and digital pathology solutions, providing services like precision histology, immunost…
ImmPACT Bio USA is developing novel therapies that will improve current T-cell therapy by addressing the need to differentiate cancerous from non-cancerous tissues to increase saf…
Pioneering the discovery of membrane-permeable & orally available cyclic-peptides. Insamo's mission is to transform how we discover drugs for some of the most challenging diseases…
Labrys Biologics is a private, venture-financed development stage biotechnology company focused on treatments for chronic migraine and episodic migraine. It has developed RN-307,…
Marrow Therapeutics is developing precision medicines to transform the lives of people with sickle cell disease, beta thalassemia and other severe blood diseases. We specifically…
Building the next generation of therapeutics
Myoventive is a precision-cardiology therapeutics company developing next-generation RNA-based medicines to transform the treatment of genetic heart disease. Bringing together a s…
Neurogastrx is a privately held, late clinical-stage biopharmaceutical company focused on identifying and developing therapies for patients suffering from serious gastrointestinal…
NFlection is a clinical-stage biopharmaceutical company focused on the development of novel therapies to address the needs of patients with neurofibromatosis type 1, immunosuppres…
Nuvera Communications provides telecommunications services, including broadband internet and digital TV. It also offers business networking solutions and has a history dating back…
NorthSea Therapeutics B.V. is a late-stage clinical biotechnology company developing novel and innovative strategies for the treatment of metabolic, cholestatic and fibrotic disea…
Oak Hill Bio is a clinical-stage biotechnology company focused on acquiring and developing outstanding rare disease drugs that have been deprioritized by big pharma. The company's…
Parabilis is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking biologically important target…
Seragon is focused on developing new treatments for estrogen-driven cancers based on its Selective Estrogen Receptor Degrader (SERD) platform. The company aims to create orally ac…
Tallac Therapeutics is a biopharmaceutical company focused on cancer immunotherapy, utilizing antibody drug conjugates to trigger immune activation.
Turning Point Therapeutics Inc (TP therapeutics) is a biopharmaceutical company that designs and develops clinical stage small molecule, targeted oncology therapies to address key…
Yarrow Bioscience is a biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases, particularly YB-101 for Graves’ disease and thyroid ey…
Axonis Therapeutics is a Boston-based, neuro-focused biotechnology company developing first- and best-in-class medicines targeting KCC2, the critical mediator of inhibitory neurot…